감염 제어 시장 보고서 : 유형, 최종사용자, 지역별(2026-2034년)

The global infection control market size reached USD 29.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 51.1 Billion by 2034, exhibiting a growth rate (CAGR) of 5.97% during 2026-2034. North America dominates the market because of robust healthcare infrastructure and widespread adoption of sterilization and disinfection technologies. Moreover, the rapid technological advancements in diagnostic and infection control equipment, the increasing demand in veterinary and animal care settings, rising R&D in infectious disease prevention, and the growing focus on preventing healthcare-associated infections (HAIs) are some of the factors propelling the market growth.

Awareness about hygiene and safety among the public and institutions is rising considerably. Healthcare providers emphasize sterilization and hygiene to avoid cross-contamination. This consciousness spreads to patients, motivating institutions to allocate more resources to infection control. The drive for safer surroundings is consistently driving the need for enhanced products and protocols in the industry. Furthermore, ongoing advancements in disinfection tools and supplies are enhancing both their efficacy and user-friendliness. Automated sterilization systems, enhanced chemical formulations, and real-time monitoring tools are now easily available. These innovations improve results while lowering labor and long-term expenses, making them appealing investments for contemporary healthcare operations. Besides this, the increase in elective and emergency surgeries results in a greater need for sterile environments. Surgical suites necessitate rigorous infection control measures, involving a wide array of supplies and instruments. With the rise in surgical volumes, the necessity for uniform infection control grows, making it a key area of focus for healthcare institutions.

Infection Control Market Trends:

Increasing Geriatric Population

There has been a notable rise in the global geriatric population, which plays a crucial role in shaping the infection control market. As projected by the World Health Organization (WHO), by the year 2030, one in six people globally will be aged 60 and above, with the worldwide senior population anticipated to rise from 1 billion in 2020 to approximately 1.4 billion by 2030. By the year 2050, this figure is expected to be around 2.1 billion. This change in demographics directly affects healthcare systems, as older individuals commonly exhibit weaker immune responses and increased vulnerability to infections. As a result, the need for strict infection control measures in hospitals, nursing homes, and long-term care facilities is growing consistently. Upholding rigorous hygiene standards and implementing cutting-edge sterilization methods are crucial in managing this age demographic. These factors further positively influence the infection control market forecast.

Rising Prevalence of Healthcare-Associated Infections (HAI)

The growing frequency of healthcare-associated infections (HAIs) in hospitals and clinical environments in different areas is emerging as a significant issue, considerably driving the need for efficient infection control strategies. Frequent forms of HAIs, including surgical site infections, catheter-related infections, and ventilator-related pneumonia, represent significant health dangers to patients and lead to prolonged hospitalizations, rising healthcare costs, and elevated morbidity rates. A publication from the European Centre for Disease Prevention and Control indicates that nearly 4.3 million hospital patients in the EU/EEA acquire at least one HAI each year. This concerning statistic highlights the critical necessity for improved infection prevention measures and the implementation of cutting-edge disinfection and sterilization technologies. Healthcare providers are progressively allocating resources to infection control products to guarantee patient safety and adhere to rigorous regulatory requirements. The increasing focus on lowering infection rates is strengthening the growth of the infection control industry.

Expanding Ambulatory Services Industry

The increasing transition towards outpatient services is becoming a major factor in driving the demand for infection control products and technologies. These outpatient care centers, providing medical services without the need for overnight hospital admissions, are becoming more popular because of their convenience, affordability, and accessibility. As reported by the publisher Group, the worldwide ambulatory services market attained a valuation of US$ 3.8 Trillion in 2023 and is expected to expand to US$ 6.3 Trillion by 2032, with a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032. As a result of this expansion, the number of patients receiving care in outpatient settings is increasing, which heightens the need for strict infection control measures. Due to high patient turnover, swift treatment cycles, and the necessity to avert cross-contamination, these facilities demand dependable sterilization, surface disinfection, and personal protective measures. The rising emphasis on safety and regulatory adherence in outpatient settings is anticipated to boost the infection control market revenue.

Infection Control Market Growth Drivers:

Technological Advancement and Product Innovation

Advancements in technology for disinfection and sterilization are transformed the infection control market, enhancing its precision, efficiency, and compatibility with changing clinical needs. Advancements in materials, automated systems, chemical substances, and monitoring platforms are enhancing reliability and safety in infection control. A prominent instance is the 2024 introduction of Getinge's Poladus 150, a low-temperature VH2O2 sterilizer designed specifically for heat-sensitive surgical tools. It featured cutting-edge cross-contamination prevention technology designed to minimize healthcare-related infections while optimizing processes in sterile supply units. The system also connected with digital platforms, providing improved traceability and operational effectiveness during hospital reprocessing. Such innovations enable healthcare personnel to execute sterilization procedures with improved uniformity and reduced mistakes. The focus on automation, traceable systems, and intuitive interfaces is minimizing labor-heavy tasks and enhanced adherence to regulations. With increasing awareness among healthcare providers regarding the cost and safety advantages of these technologies, their adoption is accelerating.

Public Health Campaigns and Government Initiatives

Public health campaigns and policy initiatives led by the government are vital in enhancing infection control measures. These initiatives enhance awareness about hygiene, encourage responsible use of antimicrobials, and advocate for best practices in clinical and community environments. Governing bodies frequently assign resources to enhance infection control systems in public hospitals, provide incentives for adherence, and back surveillance initiatives that track infection patterns. National healthcare strategies are progressively prioritizing infection prevention as a key goal, making sure that institutions align with wider health objectives. Educational outreach aimed at both healthcare professionals and the general public reinforces behavior modifications that help lower transmission risks. These campaigns also increase the demand for standardized items, such as disinfectants, sterilization devices, and protective gear. These initiatives enhance public safety while generating ongoing demand, especially in developing areas where awareness and infrastructure are still growing.

Industry Collaboration

Collaborative efforts between manufacturers of medical devices and healthcare stakeholders are essential in promoting the expansion of the infection control market. These collaborations promote awareness, education, and availability of cutting-edge technologies that tackle critical healthcare issues, especially in preventing infections. A recent instance is the collaborative effort by Bactiguard and BD at CRITICARE 2025 in India, where both organizations highlighted the significance of addressing healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), especially in intensive care settings. Throughout the event, clinical sessions emphasized the advantages of Bactiguard-coated catheters in decreasing catheter-associated urinary tract infections (CAUTI) and promoting responsible antibiotic usage. BD has also revealed the imminent release of these cutting-edge devices in the Indian market. These initiatives not only introduce advanced technologies to areas with significant needs but also strengthen the importance of industry partnerships in promoting worldwide infection control objectives, improving patient safety, and broadening market access.

Global Infection Control Industry Segmentation:

The publisher provides an analysis of the key trends in each segment of the global infection control market report, along with forecasts at the global, regional, and country levels from 2026-2034. Our report has categorized the market based on type and end user.

Breakup by Type:

• Equipment
• Disinfectors
• Washers
• Flushers
• Ultrasonic Cleaners
• Sterilization Equipment
• Heat Sterilization
• Low Temperature Sterilization
• Radiation Sterilization
• Filtration-Based Sterilization
• Others
• Services
• Contract Sterilization
• ETO Sterilization
• Gamma Sterilization
• E-Beam Sterilization
• Steam Sterilization
• Infectious Waste Disposal
• Consumables
• Disinfectants
• Sterilization Consumables
• Personal Protective Equipment
• Others

Consumables dominate the market

According to the infection control market outlook, the consumables segment, including disinfectants, sterilization consumables, personal protective equipment (PPE), and other related products, is the largest market segment in the industry. These consumables play a critical role in preventing and controlling the spread of infections across various sectors, such as healthcare, food processing, and public spaces. Disinfectants are vital in healthcare facilities, laboratories, and public spaces to eliminate harmful pathogens on surfaces and minimize the risk of infections. Sterilization consumables, like autoclave bags and indicator tapes, are indispensable in maintaining sterile medical instruments and equipment conditions.

Breakup by End User:

• Hospitals and Clinics
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Companies
• Others

Hospitals and clinics dominate the market

According to the infection control market overview, the hospitals and clinics segment emerged as the largest market share holder in the industry, reflecting the critical role of infection prevention measures in healthcare settings. Hospitals and clinics are high-risk environments where vulnerable patients, healthcare professionals, and visitors come into close contact, making them susceptible to infectious diseases. Infection control is of utmost importance in these settings to curb the spread of healthcare-associated infections (HAIs) and safeguard patient safety. Strict protocols, including hand hygiene, sterilization of medical equipment, and the use of personal protective equipment (PPE), are integral to maintaining a safe and sterile environment. Besides this, with a growing focus on patient care, hospital accreditation, and regulatory compliance, the demand for these solutions in hospitals and clinics remains robust. As healthcare facilities strive to enhance infection prevention measures and reduce the burden of HAIs, the hospitals and clinics segment is expected to continue leading the market.

Breakup by Region:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection control market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Russia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

According to the infection control market statistics, North America, comprising the United States and Canada, dominate the market, which can be attributed to several key factors driving its growth. The region's significant aging population contributes to the rising demand for infection control measures. For instance, according to an article published by the Population Reference Bureau, the number of people in the United States aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050 (a 47% increase), with the 65-and-over age group accounting for 17% to 23% of the overall population. Moreover, the region's technologically advanced healthcare infrastructure fosters the adoption of innovative infection control solutions, including advanced disinfectants, sterilization technologies, and smart medical devices.

Competitive Landscape:

Top companies catalyze the market by introducing innovative solutions and technologies to combat infectious diseases. These companies invest heavily in research and development, creating cutting-edge disinfection and sterilization products that effectively prevent the spread of infections. Their commitment to maintaining stringent quality standards and adherence to regulatory guidelines instills trust among healthcare providers, bolstering their market presence. Moreover, these companies actively engage in educational programs and awareness campaigns, emphasizing the importance of infection prevention and control measures. Continued efforts to expand their global footprint through strategic collaborations and acquisitions further fuel market growth. They address environmental concerns and attract environmentally-conscious consumers by prioritizing sustainability and eco-friendly practices.

The infection control market research report has provided a comprehensive analysis of the competitive landscape in the infection control market. Detailed profiles of all major companies have also been provided.

• 3M Company
• Advanced Sterlization Products Services Inc. (Fortive Corporation)
• Belimed AG (Metall Zug)
• Cantel Medical Corp.
• Getinge AB
• Matachana
• Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)
• MMM Munchener Medizin Mechanik GmbH
• Pal International
• Sterigenics U.S. LLC (Sotera Health Holdings LLC)
• Steris Corporation
• TSO3 Inc. (Stryker Corporation)

Key Questions Answered in This Report:

• How has the global infection control market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global infection control market?
• What is the impact of each driver, restraint, and opportunity on the global infection control market?
• What are the key regional markets?
• Which countries represent the most attractive infection control market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the global infection control market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the global infection control market?
• What is the competitive structure of the global infection control market?
• Who are the key players/companies in the global infection control market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Infection Control Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Equipment
  • 6.1.1 Market Trends
  • 6.1.2 Major Types
    • 6.1.2.1 Disinfectors
      • 6.1.2.1.1 Washers
      • 6.1.2.1.2 Flushers
      • 6.1.2.1.3 Ultrasonic Cleaners
    • 6.1.2.2 Sterilization Equipment
      • 6.1.2.2.1 Heat Sterilization
      • 6.1.2.2.2 Low Temperature Sterilization
      • 6.1.2.2.3 Radiation Sterilization
      • 6.1.2.2.4 Filtration-Based Sterilization
    • 6.1.2.3 Others
  • 6.1.3 Market Forecast
• 6.2 Services
  • 6.2.1 Market Trends
  • 6.2.2 Major Types
    • 6.2.2.1 Contract Sterilization
      • 6.2.2.1.1 ETO Sterilization
      • 6.2.2.1.2 Gamma Sterilization
      • 6.2.2.1.3 E-Beam Sterilization
      • 6.2.2.1.4 Steam Sterilization
    • 6.2.2.2 Infectious Waste Disposal
  • 6.2.3 Market Forecast
• 6.3 Consumables
  • 6.3.1 Market Trends
  • 6.3.2 Major Types
    • 6.3.2.1 Disinfectants
    • 6.3.2.2 Sterilization Consumables
    • 6.3.2.3 Personal Protective Equipment
    • 6.3.2.4 Others
  • 6.3.3 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals and Clinics
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Medical Device Companies
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Clinical Laboratories
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Pharmaceutical Companies
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Others
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 3M Company
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Advanced Sterlization Products Services Inc. (Fortive Corporation)
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Belimed AG (Metall Zug)
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Cantel Medical Corp.
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Getinge AB
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 Matachana
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
  • 13.3.7 Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc)
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
  • 13.3.8 MMM Munchener Medizin Mechanik GmbH
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
  • 13.3.9 Pal International
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
  • 13.3.10 Sterigenics U.S. LLC (Sotera Health Holdings LLC)
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
  • 13.3.11 Steris Corporation
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
  • 13.3.12 TSO3 Inc. (Stryker Corporation)
    • 13.3.12.1 Company Overview
    • 13.3.12.2 Product Portfolio